Cargando…
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
BACKGROUND: Repurposing has become a mainstream strategy in drug development, but it faces multiple challenges, amongst them the increasing and ever changing regulatory framework. This is the second study of a series of three-part publication project with the ultimate goal of understanding the marke...
Autores principales: | Murteira, Susana, Millier, Aurélie, Ghezaiel, Zied, Lamure, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865781/ https://www.ncbi.nlm.nih.gov/pubmed/27226839 http://dx.doi.org/10.3402/jmahp.v2.22813 |
Ejemplares similares
-
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
por: Murteira, Susana, et al.
Publicado: (2013) -
Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
por: Murteira, Susana, et al.
Publicado: (2014) -
New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017) -
An exploration of reformulation efforts by the food industry in Ireland
por: McMenemy, D, et al.
Publicado: (2022)